India’s apex drug regulator has allowed Pune-based Serum Institute of India to conduct late-stage — Phase 2 and 3 — human trials in India for the Oxford University Covid-19 vaccine candidate.
from Times of India https://ift.tt/39ZeN7J
via
Post Top Ad
Responsive Ads Here
Tuesday, 4 August 2020
Serum gets DCGI nod for Phase 2 & 3 trials
Tags
# Times of India
Share This
About Digipreneur Ashish
Times of India
Labels:
Times of India
Subscribe to:
Post Comments (Atom)
Post Bottom Ad
Responsive Ads Here
Author Details
Templatesyard is a blogger resources site is a provider of high quality blogger template with premium looking layout and robust design. The main mission of templatesyard is to provide the best quality blogger templates which are professionally designed and perfectlly seo optimized to deliver best result for your blog.
No comments:
Post a Comment